Literature DB >> 34001847

Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq.

Bing He1, Shuning Liu1, Yuanyuan Wang1, Mengxin Xu1, Wei Cai1, Jia Liu2, Wendi Bai1, Shupei Ye3, Yong Ma1, Hengrui Hu2, Huicui Meng1, Tao Sun4,5, Yanling Li1, Huanle Luo1, Mang Shi6, Xiangjun Du1, Wenjing Zhao7, Shoudeng Chen8, Jingyi Yang2, Haipeng Zhu9, Yusheng Jie10, Yuedong Yang11, Deyin Guo6, Qiao Wang12, Yuwen Liu13,14,15, Huimin Yan2, Manli Wang2, Yao-Qing Chen16,17.   

Abstract

B cell response plays a critical role against SARS-CoV-2 infection. However, little is known about the diversity and frequency of the paired SARS-CoV-2 antigen-specific BCR repertoire after SARS-CoV-2 infection. Here, we performed single-cell RNA sequencing and VDJ sequencing using the memory and plasma B cells isolated from five convalescent COVID-19 patients, and analyzed the spectrum and transcriptional heterogeneity of antibody immune responses. Via linking BCR to antigen specificity through sequencing (LIBRA-seq), we identified a distinct activated memory B cell subgroup (CD11chigh CD95high) had a higher proportion of SARS-CoV-2 antigen-labeled cells compared with memory B cells. Our results revealed the diversity of paired BCR repertoire and the non-stochastic pairing of SARS-CoV-2 antigen-specific immunoglobulin heavy and light chains after SARS-CoV-2 infection. The public antibody clonotypes were shared by distinct convalescent individuals. Moreover, several antibodies isolated by LIBRA-seq showed high binding affinity against SARS-CoV-2 receptor-binding domain (RBD) or nucleoprotein (NP) via ELISA assay. Two RBD-reactive antibodies C14646P3S and C2767P3S isolated by LIBRA-seq exhibited high neutralizing activities against both pseudotyped and authentic SARS-CoV-2 viruses in vitro. Our study provides fundamental insights into B cell response following SARS-CoV-2 infection at the single-cell level.

Entities:  

Mesh:

Year:  2021        PMID: 34001847      PMCID: PMC8127497          DOI: 10.1038/s41392-021-00610-7

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN: 2059-3635


  55 in total

1.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

Authors:  Sudhir Kumar; Glen Stecher; Michael Li; Christina Knyaz; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

2.  A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.

Authors:  Rui Shi; Chao Shan; Xiaomin Duan; Zhihai Chen; Peipei Liu; Jinwen Song; Tao Song; Xiaoshan Bi; Chao Han; Lianao Wu; Ge Gao; Xue Hu; Yanan Zhang; Zhou Tong; Weijin Huang; William Jun Liu; Guizhen Wu; Bo Zhang; Lan Wang; Jianxun Qi; Hui Feng; Fu-Sheng Wang; Qihui Wang; George Fu Gao; Zhiming Yuan; Jinghua Yan
Journal:  Nature       Date:  2020-05-26       Impact factor: 49.962

3.  Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.

Authors:  Mingfeng Liao; Yang Liu; Jing Yuan; Yanling Wen; Gang Xu; Juanjuan Zhao; Lin Cheng; Jinxiu Li; Xin Wang; Fuxiang Wang; Lei Liu; Ido Amit; Shuye Zhang; Zheng Zhang
Journal:  Nat Med       Date:  2020-05-12       Impact factor: 53.440

Review 4.  The Individual and Population Genetics of Antibody Immunity.

Authors:  Corey T Watson; Jacob Glanville; Wayne A Marasco
Journal:  Trends Immunol       Date:  2017-05-20       Impact factor: 16.687

5.  Structural basis of a shared antibody response to SARS-CoV-2.

Authors:  Meng Yuan; Hejun Liu; Nicholas C Wu; Chang-Chun D Lee; Xueyong Zhu; Fangzhu Zhao; Deli Huang; Wenli Yu; Yuanzi Hua; Henry Tien; Thomas F Rogers; Elise Landais; Devin Sok; Joseph G Jardine; Dennis R Burton; Ian A Wilson
Journal:  Science       Date:  2020-07-13       Impact factor: 47.728

6.  Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.

Authors:  Christoph Kreer; Matthias Zehner; Timm Weber; Meryem S Ercanoglu; Lutz Gieselmann; Cornelius Rohde; Sandro Halwe; Michael Korenkov; Philipp Schommers; Kanika Vanshylla; Veronica Di Cristanziano; Hanna Janicki; Reinhild Brinker; Artem Ashurov; Verena Krähling; Alexandra Kupke; Hadas Cohen-Dvashi; Manuel Koch; Jan Mathis Eckert; Simone Lederer; Nico Pfeifer; Timo Wolf; Maria J G T Vehreschild; Clemens Wendtner; Ron Diskin; Henning Gruell; Stephan Becker; Florian Klein
Journal:  Cell       Date:  2020-09-17       Impact factor: 41.582

7.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

8.  CD-HIT: accelerated for clustering the next-generation sequencing data.

Authors:  Limin Fu; Beifang Niu; Zhengwei Zhu; Sitao Wu; Weizhong Li
Journal:  Bioinformatics       Date:  2012-10-11       Impact factor: 6.937

9.  T-Bet+ IgM Memory Cells Generate Multi-lineage Effector B Cells.

Authors:  Kevin J Kenderes; Russell C Levack; Amber M Papillion; Berenice Cabrera-Martinez; Lisa M Dishaw; Gary M Winslow
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

10.  Commonality despite exceptional diversity in the baseline human antibody repertoire.

Authors:  Bryan Briney; Anne Inderbitzin; Collin Joyce; Dennis R Burton
Journal:  Nature       Date:  2019-01-21       Impact factor: 49.962

View more
  16 in total

Review 1.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

2.  Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccination.

Authors:  Hye Kyung Lee; Manuela A Hoechstetter; Maike Buchner; Trang Thu Pham; Jin Won Huh; Katharina Müller; Sabine Zange; Heiner von Buttlar; Philipp Girl; Roman Wölfel; Lisa Brandmeier; Lisa Pfeuffer; Priscilla A Furth; Clemens-Martin Wendtner; Lothar Hennighausen
Journal:  medRxiv       Date:  2022-09-21

Review 3.  Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges.

Authors:  Jasmin Hassan; Charlotte Haigh; Tanvir Ahmed; Md Jasim Uddin; Diganta B Das
Journal:  Pharmaceutics       Date:  2022-05-16       Impact factor: 6.525

4.  Characterization of B cell receptor H-CDR3 repertoire of spleen in PRV-infected mice.

Authors:  Lishuang Deng; Fan Yang; Zhiwen Xu; Fengqin Li; Jun Zhao; Huidan Deng; Zhijie Jian; Siyuan Lai; Xiangang Sun; Ling Zhu
Journal:  BMC Vet Res       Date:  2022-06-17       Impact factor: 2.792

5.  Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients.

Authors:  Hye Kyung Lee; Ludwig Knabl; Mary Walter; Priscilla A Furth; Lothar Hennighausen
Journal:  medRxiv       Date:  2022-05-26

6.  BOD1 regulates the cerebellar IV/V lobe-fastigial nucleus circuit associated with motor coordination.

Authors:  Xiu-Xiu Liu; Xing-Hui Chen; Zhi-Wei Zheng; Qin Jiang; Chen Li; Lin Yang; Xiang Chen; Xing-Feng Mao; Hao-Yang Yuan; Li-Li Feng; Quan Jiang; Wei-Xing Shi; Takuya Sasaki; Kohji Fukunaga; Zhong Chen; Feng Han; Ying-Mei Lu
Journal:  Signal Transduct Target Ther       Date:  2022-06-01

7.  Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination.

Authors:  Lisa Paschold; Bianca Klee; Cornelia Gottschick; Edith Willscher; Sophie Diexer; Christoph Schultheiß; Donjete Simnica; Daniel Sedding; Matthias Girndt; Michael Gekle; Rafael Mikolajczyk; Mascha Binder
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

8.  The Relationship Between Convergent IGH Signatures and Severity of COVID-19 Patients by Next-Generation Sequencing of B-Cell Repertoire.

Authors:  Hongliu Cai; Juan Hu; Lingtong Huang; Chunhua Gao; Mi Xu; Yuzhi Gao; Tao Sun; Xueling Fang
Journal:  Front Microbiol       Date:  2022-02-09       Impact factor: 5.640

9.  Current strategies for detecting functional convergence across B-cell receptor repertoires.

Authors:  Matthew I J Raybould; Anthony R Rees; Charlotte M Deane
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

10.  COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts.

Authors:  Tommi Välikangas; Sini Junttila; Kalle T Rytkönen; Anu Kukkonen-Macchi; Tomi Suomi; Laura L Elo
Journal:  Front Genet       Date:  2022-08-05       Impact factor: 4.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.